Mechanism of Breast Cancer Preventive Action of Pomegranate: Disruption of Estrogen Receptor and Wnt/β-Catenin Signaling Pathways. (Q52666613)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26703530%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Mechanism of Breast Cancer Preventive Action of Pomegranate: Disruption of Estrogen Receptor and Wnt/β-Catenin Signaling Pathways (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26703530%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Animesh Mandal

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26703530%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Anupam Bishayee

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26703530%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

English

0 references

publication date

12 December 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26703530%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26703530%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26703530%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26703530%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

22315-22328

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26703530%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

3 March 2020

copyright license

start time

12 December 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

21 January 2018

Cancer statistics, 2015

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Retention and use of breast cancer recurrence risk information from genomic tests: the role of health literacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Hereditary breast cancer: new genetic developments, new therapeutic avenues

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Chemoprevention for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Child maltreatment and breast cancer survivors: social support makes a difference for quality of life, fatigue and cancer stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Hormone replacement therapy and the risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Alcohol consumption and breast cancer risk among women from five ethnic groups with light to moderate intakes: the Multiethnic Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Does night work increase the risk of breast cancer? A systematic review and meta-analysis of epidemiological studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Breast cancer chemoprevention: old and new approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Citrus fruit intake and breast cancer risk: a quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Green tea consumption and breast cancer risk or recurrence: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Soy food consumption and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Dietary compared with blood concentrations of carotenoids and breast cancer risk: a systematic review and meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Nutrition and survival after the diagnosis of breast cancer: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Potential utility of natural products as regulators of breast cancer-associated aromatase promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Modulation of angiogenesis by dietary phytoconstituents in the prevention and intervention of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Chemopreventive and chemotherapeutic potential of curcumin in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Influence of berry polyphenols on receptor signaling and cell-death pathways: implications for breast cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Chemoprevention of breast cancer by dietary compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Breast cancer and flavonoids - a role in prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Effect of green tea catechins on breast carcinogenesis: a systematic review of in-vitro and in-vivo experimental studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Oleanane triterpenoids in the prevention and therapy of breast cancer: current evidence and future perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Phytochemicals for breast cancer therapy: current status and future implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Pomegranate as a functional food and nutraceutical source

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

The bioactivity of pomegranate: impact on health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Pomegranate extracts and cancer prevention: molecular and cellular activities

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Potential Effects of Pomegranate Polyphenols in Cancer Prevention and Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Pomegranate fruit extract impairs invasion and motility in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

The antioxidant potency of Punica granatum L. Fruit peel reduces cell proliferation and induces apoptosis on breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Pomegranate juice and specific components inhibit cell and molecular processes critical for metastasis of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Pomegranate extract demonstrate a selective estrogen receptor modulator profile in human tumor cell lines and in vivo models of estrogen deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Breast cancer chemopreventive properties of pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Pomegranate exerts chemoprevention of experimentally induced mammary tumorigenesis by suppression of cell proliferation and induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Estrogen signaling: a subtle balance between ER alpha and ER beta

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

The role of oestrogen in the pathogenesis of obesity, type 2 diabetes, breast cancer and prostate disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Experimentally induced mammary tumors in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Up-regulation of CacyBP/SIP during rat breast cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Estrogen carcinogenesis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Estrogen receptors alpha and beta in the rodent mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Preventive therapy for breast cancer: a consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Wnt proteins in mammary development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Key signaling nodes in mammary gland development and cancer: β-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Wnt/beta-catenin signaling in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Cytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

beta-Catenin signaling: therapeutic strategies in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Pomegranate Bioactive Constituents Suppress Cell Proliferation and Induce Apoptosis in an Experimental Model of Hepatocellular Carcinoma: Role of Wnt/ β -Catenin Signaling Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Effects of fruit ellagitannin extracts, ellagic acid, and their colonic metabolite, urolithin A, on Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Inhibitory effect of a standardized pomegranate fruit extract on Wnt signalling in 1, 2-dimethylhydrazine induced rat colon carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Cell cycle proteins in epithelial cell differentiation: implications for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Cyclin D1 and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Gene expression profiling in the mammary gland of rats treated with 7,12-dimethylbenz[a]anthracene

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Mechanisms of combined action of different chemopreventive dietary compounds: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Epigallocatechin 3-gallate and green tea catechins: United they work, divided they fail

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Pomegranate-mediated chemoprevention of experimental hepatocarcinogenesis involves Nrf2-regulated antioxidant mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Chemoprevention of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3390%2FMOLECULES201219853

Expression patterns of beta-catenin in in situ and invasive breast cancer

21 January 2018

1 reference

12 December 2020

Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors.

1 reference

12 December 2020

ER beta inhibits proliferation and invasion of breast cancer cells

1 reference

12 December 2020

Increased fruit, vegetable and fiber intake and lower fat intake reported among women previously treated for invasive breast cancer

1 reference

12 December 2020

Etiology-specific gene expression profiles in rat mammary carcinomas.

1 reference

12 December 2020

Etiology of hormone receptor-defined breast cancer: a systematic review of the literature

1 reference

12 December 2020

Alterations and correlations of the components in the Wnt signaling pathway and its target genes in breast cancer.

1 reference

12 December 2020

Chemoprevention of breast cancer with selective oestrogen-receptor modulators

1 reference

12 December 2020

Wnt signaling pathway in invasive ductal carcinoma of the breast: relationship between beta-catenin, dishevelled and cyclin D1 expression

1 reference

12 December 2020

Therapeutic applications of pomegranate (Punica granatum L.): a review.

1 reference

12 December 2020

Pomegranate extract inhibits the proliferation and viability of MMTV-Wnt-1 mouse mammary cancer stem cells in vitro

1 reference

12 December 2020

Evaluation of antioxidant, antitumor and immunomodulatory properties of polysaccharide isolated from fruit rind of Punica granatum

1 reference

12 December 2020

Dietary supplements and natural products in breast cancer trials

1 reference

12 December 2020

Antiproliferative effects of pomegranate extract in MCF-7 breast cancer cells are associated with reduced DNA repair gene expression and induction of double strand breaks

1 reference

12 December 2020

Male breast cancer: a rare disease that might uncover underlying pathways of breast cancer

1 reference

12 December 2020

Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes

1 reference

12 December 2020

Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis.

1 reference

12 December 2020

10.3390/MOLECULES201219853

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26703530%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26703530%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

PubMed publication ID

26703530

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26703530%20AND%20SRC:MED&resulttype=core&format=json